Noerr advises Fresenius Medical Care on successful placement of US$500m bond

Noerr has again advised Fresenius Medical Care on successfully floating a US$500 million bond via its wholly-owned subsidiary Fresenius Medical Care US Finance III, Inc. With a term of 10 years and a coupon of 3.750% p.a., the bond was offered to institutional investors in a private placement.

The issue proceeds will be used by the company for general business purposes and for refinancing its maturing debt. Fresenius Medical Care will apply for the bond to be admitted to trading on the Regulated Market of the Luxembourg Stock Exchange.

Holger Alfes and Julian Schulze De la Cruz led the team advising the client on this bond issue. Last year, a team coordinated by the two Frankfurt-based capital markets experts already advised on FMC’s first-time setting up of a euro medium-term notes (EMTN) programme totalling up to €10 billion and the issue of a €500 million bond. Noerr advises Fresenius Medical Care regularly, especially also on financing law issues.

Advisors to Fresenius Medical Care AG & Co. KGaA: Noerr LLP

Dr Holger Alfes, Dr Julian Schulze De la Cruz (joint lead), Dr Dominik Kloka, Dr Dirk Buken, Elisabeth Heuser (all Capital Markets, Frankfurt), Martin Haisch, Matthias Geurts (both Tax, Frankfurt)

US law: Baker & McKenzie LLP

Robert A. Grauman, Thomas J. Rice, Elizabeth Paek

In-house: Dr Caroline Redeker, Hans-Christian Mick